← All stocks

UPEXI, INC.

UPXI Net buying
CIK 0001775194 #4559 in the set updated 19 Sep 2026
Bought (12 mo)
$1.07M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$1.07M
+$1.07M against sales at will

By person

6 insiders · 6 transactions
12.9×

Allan Marshall holds 12.9 times base salary in stock. $10.88M of shares against $840.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Allan Marshall last reported holding, valued at $1.80, the price Common Stock was last bought or sold at on the open market here, on 23 Dec 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Salkind Gene
Director
$673.50K (3)
+$673.50K
537,500
$967.50K
MARSHALL ALLAN
Chief Executive Officer
$400.50K (3)
+$400.50K
6,046,261
$10.88M
+3,893%
Rudick Brian Benjamin
Chief Strategy Officer
1,238,597
$2.23M
+182.4%
Norstrud Andrew James
Chief Financial Officer
1,049,138
$1.89M
+311.0%
Dugan Lawrence
Director
216,389
$389.50K
+55,527%
Williams Thomas Charles
Director
100,000
$180.00K

No percentages here. This company's share count has moved by a factor of 67.5 over the window, from 1,040,924 to 70,261,828 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
MARSHALL ALLAN
23 Dec 2025
Chief Executive Officer
Buy
50,000
$1.80
$90.00K
MARSHALL ALLAN
16 Dec 2025
Chief Executive Officer
Buy
50,000
$2.07
$103.50K
MARSHALL ALLAN
15 Dec 2025
Chief Executive Officer
Buy
100,000
$2.07
$207.00K
Salkind Gene
20 Nov 2025
Director
Buy indirect
50,000
$2.55
$127.50K
Salkind Gene
17 Nov 2025
Director
Buy indirect
100,000
$2.81
$281.00K
Salkind Gene
17 Nov 2025
Director
Buy
100,000
$2.65
$265.00K

What was left out

Form 4 filings counted 10
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 4,840,000
History held since 30 Aug 2021